Skip to main content
Margaret Kasner, MD, Oncology, Philadelphia, PA, Thomas Jefferson University Hospital

MargaretTKasnerMDMSCE

Oncology Philadelphia, PA

Hematologic Oncology

Professor of Medical Oncology, Thomas Jefferson University

Dr. Kasner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Kasner's full profile

Already have an account?

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2004 - 2007
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 2001 - 2004
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 2001

Certifications & Licensure

  • DE State Medical License
    DE State Medical License 2018 - 2025
  • NJ State Medical License
    NJ State Medical License 2017 - 2025
  • PA State Medical License
    PA State Medical License 2001 - 2024
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Regional Top Doctor Castle Connolly, 2014
  • Patient-Centered Specialty Practice Recognition Program National Committee for Quality Assurance, 2014-2017
  • CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2012

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • OPB-111077 in Combination with Decitabine and Venetoclax for the Treatment of Acute Myeloid Leukemia
    Margaret Kasner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

  • A phase I trial of palbociclib in combination with dexamethasone in relapsed or refractory adult B-cell acute lymphoblastic leukemia (ALL). 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • How to Discuss Cancer Prognosis with Patients & Family
    How to Discuss Cancer Prognosis with Patients & FamilySeptember 5th, 2019

Professional Memberships

Hospital Affiliations